MVA newsletter no 1, January 2004
: NEWS INDEX
- Medicon Valley HR Network meeting / 28 January 2004
- Stina Gestrelius, MVA, has been appointed as Swedish delegate in newly founded Nordic Innovation Centre
- Medicon Valley Annual BioMeeting 2004 / 31 March 2004
- MVA - Tronheim partnership
- Danish CRO company Medicon to conduct study for US biotech company
- New Danish fund for high technological research
- Breakthrough for Swedish CellaVision in USA
- European stem cell research boost for Lund
- New Danish nanotech company in Medicon Valley
: MVA NEWS
Medicon Valley HR Network meeting
28 January 2004 / Øresundshuset / Copenhagen
The second HR network meeting concerning the issues on working/living across Øresund; taxes, employment, VAT, insurance, wages etc.
More Information... (Swedish) www.mva.org/composite-733.htm
Stina Gestrelius, MVA, has been appointed as Swedish delegate in newly founded Nordic Innovation Centre
The two institutions which to date have been responsible for the Nordic Council of Ministers‘ initiatives in the business sector - the Nordic Industrial Fund and Nordtest - merged 1 January 2004 to become the Nordic Innovation Centre.
More information... (English) www.mva.org/composite-884.htm
Medicon Valley Annual BioMeeting 2004
31 March 2004 / Börshuset / Malmö
Medicon Valley Academy invites to a half-day conference for scientists and business representatives from universities, hospitals and industry in the Øresund region (Medicon Valley).
More Informtion... (English) www.mva.org/composite-720.htm
MVA - Tronheim partnership
Life science network in Tronheim, Norway, and Medicon Valley Academy join forces to enhance the future Scandinavian global competitiveness.
More Information... (English) www.mva.org/composite-859.htm
: MEDICON VALLEY NEWS
Danish CRO company Medicon to conduct study for US biotech company
Medicon has announced that Medicon Clinical Pharmacology has been engaged by Nobex Corp. to perform its next Phase I/II clinical trial in patients with inflammatory bowel disease.
More information... (English) www.mva.org/composite-883.htm
New Danish fund for high technological research
An new Danish governmental fund with DKK 16 billion to spend, will be looking towards placing money within the promising technologies of tomorrow, such as bio- and nanotechnology.
More Information... (Danish) www.mva.org/composite-866.htm
Breakthrough for Swedish CellaVision in USA
With Sysmex America as a new partner, CellaVision progress to take in the American market and launch their CellaVision DM96 - an automated cell morphology differentiation instrument.
More Information... (Swedish) www.mva.org/composite-867.htm
European stem cell research boost for Lund
The European Commission has praised Lund as one of the top locations for biotechnology research in Europe, raising hopes that the city’s new stem cell center will land a share of a planned EUR 17 million grant from Brussels to the industry.
More Information... (English) www.mva.org/composite-862.htm
New Danish nanotech company in Medicon Valley
Atomistix, a new nanotech software company, has been established in the Nano Science Center at the University of Copenhagen in Medicon Valley.
More Information... (Danish) www.mva.org/composite-864.htm
: EVENTS
The legal challenges of the biotech- and medical industries
24-25 February 2004 / Copenhagen / Denmark
An understanding of the immense and important issues of cooperation, patenting and rights have become imperative for any biotech- and medical company today. This conference works with the legal aspects of these industries from lab to market.
More Information... (Danish) www.mva.org/composite-852.htm
Exploit the potential of your Patent
16-18 March 2004 / Copenhagen / Denmark
This conference focuses on how to incorporate and use the potential of patents in optimising the market strategy, portfolios and development.
More Information... (Danish) www.mva.org/composite-858.htm
XVIIIth International Symposium on Medicinal Chemistry
15-19 August 2004 / Copenhagen, Denmark & Malmö, Sweden
The XVIIIth International Symposium on Medicinal Chemistry will reflect that medicinal chemistry is a scientific discipline undergoing rapid development. The molecular biological revolution, new drug design technologies and the progressing mapping of the human genome have created a new exciting working field for scientists in these research areas.
More information... (English) www.mva.org/composite-881.htm
: NEW MVA MEMBERS
Pronano AB - www.pronano.se : is a not-for-profit organization, dedicated to converting nanotechnological breakthroughs into industrial products and processes, helping academic researchers to commercialise their findings, giving industrial developers easy access to academic resources and competence, and helping the existing industry to renew production methods and product lines.
Chubb Insurance Denmark - www.chubb.dk : an insurance company focusing on and providing individuals and businesses with innovative and specialized insurance programs plus services designed to help protect their assets.